ULTRAGENYX PHARMACEUTICAL INC. Increase (Decrease) in Other Noncurrent Assets
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Increase (Decrease) in Other Noncurrent Assets of -$1.08 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2019-11-06
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for the quarter ending 2019-09-30 was -$70.00K.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for the quarter ending 2019-06-30 was -$65.00K.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for the quarter ending 2019-03-31 was -$945.00K, a 464.86% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-12-31 was $315.00K.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for fiscal 2018 was $377.00K.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for fiscal 2017 was -$522.00K, a 142.03% decline from fiscal 2016.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for fiscal 2016 was $1.24M.
- ULTRAGENYX PHARMACEUTICAL INC. increase (decrease) in other noncurrent assets for fiscal 2015 was -$179.00K, a 143.55% decline from fiscal 2014.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$135.00K derived: sum of 2 quarters · filed 2019-11-06 | -$1.08M 10-Q · filed 2019-11-06 | -$765.00K derived: sum of 4 quarters · filed 2019-11-06 | |
| 2019-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$1.01M 10-Q · filed 2019-08-02 | -$695.00K derived: sum of 3 quarters · filed 2019-08-02 | -$735.00K derived: sum of 4 quarters · filed 2019-11-06 | |
| 2019-03-31 | -$945.00K 10-Q · filed 2019-05-07 | -$630.00K derived: sum of 2 quarters · filed 2019-05-07 | -$670.00K derived: sum of 3 quarters · filed 2019-11-06 | -$827.00K derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $275.00K derived: sum of 2 quarters · filed 2019-11-06 | $118.00K derived: sum of 3 quarters · filed 2019-11-06 | $377.00K 10-K · filed 2019-02-20 | |
| 2018-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$197.00K derived: sum of 2 quarters · filed 2019-11-06 | $62.00K 10-Q · filed 2019-11-06 | $32.00K derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $102.00K 10-Q · filed 2019-08-02 | $72.00K derived: sum of 3 quarters · filed 2019-08-02 | -$319.00K derived: sum of 4 quarters · filed 2019-08-02 | |
| 2018-03-31 | $259.00K 10-Q · filed 2019-05-07 | $229.00K derived: sum of 2 quarters · filed 2019-05-07 | -$162.00K derived: sum of 3 quarters · filed 2019-05-07 | -$188.00K derived: sum of 4 quarters · filed 2019-05-07 | |
| 2017-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$421.00K derived: sum of 2 quarters · filed 2019-02-20 | -$447.00K derived: sum of 3 quarters · filed 2019-02-20 | -$522.00K 10-K · filed 2019-02-20 | |
| 2017-09-30 | -$391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$417.00K derived: sum of 2 quarters · filed 2018-11-06 | -$492.00K 10-Q · filed 2018-11-06 | -$523.00K derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$101.00K 10-Q · filed 2018-08-03 | -$132.00K derived: sum of 3 quarters · filed 2019-02-20 | $290.00K derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-03-31 | -$75.00K 10-Q · filed 2018-05-08 | -$106.00K derived: sum of 2 quarters · filed 2019-02-20 | $316.00K derived: sum of 3 quarters · filed 2019-02-20 | -$301.00K derived: sum of 4 quarters · filed 2019-02-20 | |
| 2016-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $391.00K derived: sum of 2 quarters · filed 2019-02-20 | -$226.00K derived: sum of 3 quarters · filed 2019-02-20 | $1.24M 10-K · filed 2019-02-20 | |
| 2016-09-30 | $422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$195.00K derived: sum of 2 quarters · filed 2017-11-03 | $1.27M 10-Q · filed 2017-11-03 | $1.13M derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-06-30 | -$617.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $851.00K 10-Q · filed 2017-07-28 | $712.00K derived: sum of 3 quarters · filed 2018-02-21 | $656.00K derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-03-31 | $1.47M 10-Q · filed 2017-05-05 | $1.33M derived: sum of 2 quarters · filed 2018-02-21 | $1.27M derived: sum of 3 quarters · filed 2018-02-21 | $1.28M derived: sum of 4 quarters · filed 2018-02-21 | |
| 2015-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$195.00K derived: sum of 2 quarters · filed 2018-02-21 | -$186.00K derived: sum of 3 quarters · filed 2018-02-21 | -$179.00K 10-K · filed 2018-02-21 | |
| 2015-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$47.00K derived: sum of 2 quarters · filed 2016-11-08 | -$40.00K 10-Q · filed 2016-11-08 | -$91.00K derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $16.00K 10-Q · filed 2016-08-09 | -$35.00K derived: sum of 3 quarters · filed 2017-02-17 | -$339.00K derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-03-31 | $7.00K 10-Q · filed 2016-05-10 | -$44.00K derived: sum of 2 quarters · filed 2017-02-17 | -$348.00K derived: sum of 3 quarters · filed 2017-02-17 | $231.00K derived: sum of 4 quarters · filed 2017-02-17 | |
| 2014-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$355.00K derived: sum of 2 quarters · filed 2017-02-17 | $224.00K derived: sum of 3 quarters · filed 2017-02-17 | $411.00K 10-K · filed 2017-02-17 | |
| 2014-09-30 | -$304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $275.00K derived: sum of 2 quarters · filed 2015-11-10 | $462.00K 10-Q · filed 2015-11-10 | -$1.82M 10-Q · filed 2014-11-10 | $1.58M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $579.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $766.00K 10-Q · filed 2015-08-14 | $1.88M derived: sum of 3 quarters · filed 2016-02-26 | ||
| 2014-03-31 | $187.00K 10-Q · filed 2015-05-12 | $1.30M derived: sum of 2 quarters · filed 2016-02-26 | |||
| 2013-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.62M 10-K · filed 2016-02-26 | |||
| 2013-09-30 | $1.50M 10-Q · filed 2014-11-10 | ||||
| 2012-12-31 | -$8.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |